Cenupatide
Cenupatide is a uPAR inhibitor that blocks its interaction with formyl peptide receptors (FPRs) . It has been shown in a streptozotocin-induced diabetic rat model to ameliorate kidney lesions, reduce upregulated uPA activity, and suppress glomerular FPR2 expression, highlighting its utility for renal disease research.
Product Specifications
Molecular Weight
617.756
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog